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Intracellular replication of the well-armed pathogen
Burkholderia pseudomallei
Sam J Willcocks1, Carmen C Denman1, Helen S Atkins2 and
Brendan W Wren1
The Burkholderia genus contains a group of soil-dwelling
Gram-negative organisms that are prevalent in warm and
humid climates. Two species in particular are able to cause
disease in animals, B. mallei primarily infects Equus spp. and B.
pseudomallei (BPS), that is able to cause potentially life-
threatening disease in humans. BPS is naturally resistant to
many antibiotics and there is no vaccine available. Although not
a specialised human pathogen, BPS possesses a large
genome and many virulence traits that allow it to adapt and
survive very successfully in the human host. Key to this survival
is the ability of BPS to replicate intracellularly. In this review we
highlight recent advances in our understanding of the
intracellular survival of BPS, including how it overcomes host
immune defenses and other challenges to establish its niche
and then spread the infection. Knowledge of these
mechanisms increases our capacity for therapeutic
interventions against a well-armed foe.
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Introduction
Burkholderia pseudomallei (BPS) is a motile, Gram-nega-
tive saprophyte that dwells in the soil and surface water of
hot and humid countries, notably in South East Asia and
Northern Australia. It is capable of infecting a wide
variety of mammals and causes the emerging disease,
melioidosis, in humans. Pathogenicity manifests as either
a chronic pulmonary disease when particles of contami-
nated soil are inhaled, alternatively as life-threatening
septicaemia if the bacteria are introduced into the blood
stream through dermal puncture.
Humans are an accidental host and the lack of human-to-
human transmission precludes host–pathogen evolution.
Yet, BPS is very successful at survival in vivo, in part due
to genomic islands acquired through horizontal gene
transfer from other bacteria [1], and in part from adapta-
tion to environmental stress factors that confer dual
protection against host immune mechanisms. BPS pos-
sesses a large genome for a bacterium of around 7.25 mil-
lion bases spread over two chromosomes. Accordingly, it
possesses numerous virulence factors and demonstrates
remarkable plasticity in adapting to microenvironmental
conditions.
Several tools are available that help to identify virulence
factors in the context of intracellular survival. A common
approach is to compare the genome of BPS with a closely
related avirulent species, B. thailandensis. A conceptually
similar experiment is to compare virulent and attenuated
clinical isolates derived from the same strain. Molecular
based approaches such as PCR-based subtractive hybri-
disation have identified factors such as the membrane
transporter, BPSL2033 that reduces the ability of BPS to
replicate in macrophages [2]. More recently, the creation
of initially small transposon-mediated signature-tagged
mutant libraries in BPS [3] and now large scale libraries
coupled with next generation sequencing [4] have
opened new avenues to reveal the genes required by
BPS to survive intracellularly.
In this review, we highlight recent reports relating to
the mechanisms employed by BPS to survive and
thrive inside host cells; summarised in Figure 1 and
Table 1. Not only is this characteristic an essential re-
quirement for pathogenicity, it also presents targets for
the development of novel antimicrobial therapeutics
against a hardy organism that naturally tolerates many
existing antibiotics.
First contact with the host cell
BPS is not an obligate intracellular pathogen, but if
cellular defense mechanisms are overcome it offers sev-
eral advantages over an extracellular lifestyle, such as the
evasion of humoral immunity, reduced exposure to anti-
biotics, and the potential establishment of latency. Intra-
cellular living is also essential for localised spread from
the site of infection, and eventual systemic dissemination.
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The initial infection of a host cell depends upon invasion
and adhesion factors that have been well reviewed [5]. In
brief, BPS has the capability to invade cells either pas-
sively in the case of uptake by phagocytes such as resident
tissue macrophages and recruited neutrophils; or actively
in the case of epithelial cell infection. An advantageous
trait of BPS in this regard are its flagellae, which in wet
soil or aquatic environments propel the bacilli against a
concentration gradient toward nutrients that may other-
wise be scarce; and in the mammalian host, enable
penetration of protective mucous linings and surfactant
to reach epithelial cells. Other factors such as the expres-
sion of Type IV pilli are well-recognized adhesion factors,
and BPS also possesses two further proteins, BoaA and
BoaB that promote attachment to epithelial cells [6]. Host
cell factors also play a role, such as protease-activated
receptor-1, expressed by various cell types, that promotes
cell ingress and is associated with BPS growth and dis-
semination [7].
The benefits of intracellular growth seem at odds with the
characteristic of BPS to induce cell death of the infected
cell. BPS is cytotoxic to dendritic cells (DC), monocytes
and macrophages within hours of infection, with an
absolute requirement for internalisation, caspase-1 acti-
vation, and the Type Three Secretion System (T3SS) in
what has been described as a pyroptotic cell death mech-
anism [8]. The BPS flagellar hook-associated protein also
induces cytotoxicity [9]. This rapid cell death is strongly
linked to the multiplicity of infection and cell type. For
example, epithelial cells seem somewhat resistant to
BPS-mediated killing. Therefore, a low level infection
that includes infection of epithelial cells may contribute
to chronic persistence in the host, in contrast to highly
inflammatory acute infection. Concurrently, BPS inhibits
mechanisms of cell death that may control the infection
though bacterial killing; infected neutrophils, for exam-
ple, normally undergo apoptosis and are subsequently
engulfed and degraded by macrophages, destroying their
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Intracellular lifecycle summary of Burkholderia pseudomalleii. B. pseudomallei (BPS) gains access to epithelial or phagocytic cells via flagella and
adhesion-related virulence factors. BPS then goes on to expresses an arsenal of virulence factors to combat the host response. (I) Uptake and
entry: either via phagocytic cells or epithelial cells. When entering non-phagocytic cells such as epithelial cells, BPS can attach and enter host
cells. Flagella, pilli, and other adhesins BoaA and BoaB are involved in this process. Passive uptake by tissue resident macrophages or
neutrophils also occurs. (II) Survival and escape: BPS once taken up by the host cell is enveloped in an endocytic vesicle or phagasome. Upon
internalisation, B. pseudomallei is held within a phagosome, where the T3SS is required for BPS escape. Escape occurs before maturation and
killing. Resistance to oxidative stress response from the host, and production of the serine protease ecotin are also crucial steps for phagosome
survival and subsequent escape. (III) BPS replication and dissemination to surrounding cells, and fusion of neighbouring cells into MNGC’s. Once
outside the phagosome, B. pseudomallei is able to replicate host actin is utilized for the polymerisation of elegantly structured Ena/VASP-like tails.
These projections alongside the T6SS-1 result in successful dissemination to surrounding cells, resulting in the formation of multi-nucleated giant
host cells (MNGC). Black text describes intracellular process of BPS, navy text lists genes important for intracellular survival are listed, references
for which can be found in Table 1. Some of the host-combative responses are shown in red text, and the dashed-arrow indicates the connectivity
between T3SS and T6SS. Actin tails are not structurally accurate.
www.sciencedirect.com Current Opinion in Microbiology 2016, 29:94–103
96 Host-microbe interactions: bacteria
Table 1
Selection of major B. pseudomallei intracellular virulence traits and advancements in the literature. BPS locus ID from Burkholderia.com
(Winsor et al., 2008)
Genetic feature General role Reference(s) BPS locus ID
Entry and uptake into host cells
Boa
boaB
Cell attachment; adhesin; autotransporter Balder et al. [6]
Lazar Adler et al. [74]
Lazar Adler et al. [70]
BPSL1705
bpaC Cell attachment; autotransporters; adhesin;
Type V secretion system; protects from
complement killing
Campos et al. [75]
Lazar Adler et al. [70]
BPSL1631
Type IV pilli, pilA Adhesion factor and intracellular mobility Essex-Lopresti et al.;
Boddey et al.
Fla1 and fla2 locus.
Metabolism and phagosome escape
fabI -1
fabI-2
Two enoyl-ACP reductases, bpmFabI-1 and
bpmFabI-2, found in BPS one on each
chromosome, involved in antibacterial
activity
Liu et al. [53]
Cumming et al. [52]
BPSL2204
BPSS0721
(unclear if active)
sodC Superoxide dismutase/oxidoreductase Vanaporn et al. [21] BPSL1001
ahpC Alkyl hydroperoxide reductase; related to T-
cell immunity
Loprasert et al. [76]
Reynolds et al. [77]
BPSS0492
CHBP Delays host cell maturation and apoptosis;
ATP/GTP binding protein unique to BPS
Gourlay et al. [9] BPSS1385
bopA
bopE
Type three secretion system; involved in
epithelial cell invasion; attenuated in murine
model of infection
Stevens et al. [78]
Pumirat et al. [79]
Vander Broek et al. [80]
BPSS1525
bprD Intracellular survival, type three secretion
effector, virulence regulator
Vander Broek et al. [80]
Chirakul et al. [81]
spR Regulators of T3SS and T6SS LexA repressor Holden et al. [82]
Chen et al. [63]
Chen et al. [83]
BPSL1840
eco Serine protease activity releases BPS from
vesicle, inhibits elastase
Ireland et al. [33] BPSL1051
bsaN Transcriptional regulator involved in
modulation of T3SS and T6SS-1
Chen et al. [83]
Sun et al. [50]
BPSS1546
BPSS1504 Affects Hcp1 secretion and integrity of the
T6SS-1 apparatus
Hopf et al. [64] BPSS1504
bsaS T3SS-3 ATPase/ATP synthase SpaL Gong et al. [84] BPSS1541
vgrG-5 T6SS spike protein; membrane fusion;
intracellular spread
Toesca et al. [66]
Schwarz et al. [67]
BP1026B_II1596
virAG Two component system, T6SS regulators,
sensor and histidine kinase.
Chen et al. (2013) BURPS1710b_
A0530-A0532
bsaU Involved in early onset activation of caspase-
1 pathway in macrophages; T3SS
Sun et al. [50]
Bast et al. [40]
BPSS1539
purM
purN
Phosphoribosylglycinamide
formyltransferase;
phosphoribosylaminoimidazole synthetase
purine biosynthetic pathway
Breitbach et al. [54] BPSL0908
BPSL2818
fabI Enoyl-ACP reductase; type II fatty acid
biosynthesis pathway
Liu et al. [53] BPSL2204
pabB/lipB Lipoate-protein ligase B; essential for
intracellular life cycle and virulence in murine
model
Breitbach et al. [54] BPSL0413
bipD, C, B T3SS translocon proteins; phagolysosome
survival; cell invasion protein
Gong et al. [36]
Vander Broek et al. [80]
BPSS1529
BPSS1531
BPSS1532
bpscN (formerly sctC) TTSS1 ATPase; intracellular survival; murine
pathogenesis
Warawa and Woods [85]
D’Cruze et al. [86]
BPSS1390
sctN Type III secretion system ATPase Warawa and Woods [85] BPSS1394
bsaQ Type III secretion system; cell cycle inhibiting;
invasion and escape from endocytic vesicles
Muangsombut et al. [35]
Pumirat et al. [10]
BPSS1543
Spread and MNGC formation
hcp1 Tail-spike T6ss1, MNGC cell formation,
hemolysin-coregulated protein substrate and
or a secretion tube (also part of T6SS)
Burtnick et al. [87]
Lim et al. [62]
BPSS1498
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contents within a few hours, but this is delayed by BPS
infection [10,11].
The host cell response to BPS infection
The engagement of host pattern recognition receptors
during BPS infection have been well characterized, and it
has been found that the toll-like receptor repertoire offer
little protective benefit or worse, contribute to disease
severity and mortality [12–17]. This may in part be due to
the ability of BPS to resist various TLR-dependent innate
immune killing mechanisms. One such mechanism, par-
ticularly in the murine model of infection, is the genera-
tion of reactive nitrogen species (RNS). In contrast to
other Gram-negative bacteria, the LPS in the cell wall of
BPS is a weak inducer of the enzyme, iNOS, partly due to
its inability to stimulate IFN-b [18]. Accordingly, im-
pairment of iNOS activity in a murine model of infection
does not significantly alter killing capability [19]. A relat-
ed mechanism is the respiratory burst, triggered by the
engagement of pathogen associated molecular patterns
(PAMP) by TLR. Reactive oxygen species (ROS) are
able to denature enzymes as well as damage fatty acids
and DNA, and direct exposure is lethal for BPS. While the
effect of ROS-mediated killing of BPS in ex vivo isolated
macrophages or macrophage-like cell lines is modest, in
vivo studies have shown a significant role of ROS in host
survival [19].
Unlike RNS, BPS is an inducer of ROS, perhaps unavoid-
ably so. A key protein in BPS invasion of host cells is
BopE, which acts as a guanine nucleotide exchange factor
for RhoGTPases, promoting actin cytoskeleton rear-
rangement (reviewed by Allwood et al. [5]). However,
RhoGTPases also stimulate NAPH oxidase [20], promot-
ing the respiratory burst. Therefore, the ability of BPS to
neutralise ROS using proteins such as superoxide dis-
mutase is a key aspect of their virulence in vivo [21].
Whole genome analysis has further revealed that during
oxidative stress, BPS upregulates genes involved in cell
wall repair and biosynthesis, as well as the peroxide
scavenging enzymes, KatG and AhpC. Also discovered
was an oxidative stress regulon under the control of the
sigma factor, RpoE. RpoE is conserved among Gram-
negative bacteria, and deletion in BPS resulted in re-
duced intracellular survival in macrophages and virulence
in the murine model. RpoE seems to be important for
maintaining expression of spermidine acetyltransferase,
speG, under oxidative stress. Spermidine is useful for the
bacteria as it acts as a free radical scavenger but excessive
levels are toxic, and so SpeG is required to prevent its
accumulation to damaging levels [22,23].
Restricting the exposure of BPS to toxic levels of ROS in
monocytes and macrophages is potentially realised
through an additional mechanism. During the initial
hours post-BPS infection, there is a reduction in CFU
followed by growth recovery [24–26]; this temporally
correlates with activation of NADPH-oxidase that causes
rapid, but only transient ROS production. Although direct
modulation of NADPH-oxidase by BPS has not been
experimentally demonstrated, its activity, as well as a
large component of TLR-mediated signalling, depends
on the transcription factor, NfkB, which BPS has been
shown to actively inhibit. By undermining the transcrip-
tional response to TLR-activation, BPS is able to disarm a
key aspect of host immunity. The BPS virulence factor,
TssM, inactivates NfkB through deubiquitinisation of its
inhibitor, IkB, thus also impairing downstream interferon
pathway activation [27]. TssM is located upstream of the
T3SS, and downstream of the T6SS gene clusters. Dele-
tion of the T3SS bsa cluster reduces its secretion, as does
removal of the Type-Two Secretion-associated outer
membrane channel, GspD [27,28].
It has been observed over many years that there is a
clinical correlation between non-obese diabetes, predom-
inantly Type 1 diabetes mellitus, and BPS infection; it is a
recognized risk factor in endemic regions. Diabeties
mellitus is an auto-immune disease with pleiotropic
effects that generally impair the ability of the diabetic
host to control bacterial infection. For example, a de-
creased capacity of macrophages to phagocytose and kill
[29], LPS-induced generation of CD4 T-regulatory cells
and impairment of TLR-mediated MyD88 inflammatory
signalling [30].
Research into the molecular and immunological mecha-
nisms that link diabetes with BPS in particular is begin-
ning to reveal new insights into clinical observations. For
example, a further mechanism by which BPS moderates
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Table 1 (Continued )
Genetic feature General role Reference(s) BPS locus ID
bimA Escape from the phagosome;
autotransporter, actin tail formation
Stevens et al. [88]
Sitthidet et al. [89]
Lazar Adler et al. [74]
Sarovich et al. [90]
Lazar Adler et al. [70]
Benanti et al. [60]
BPSS1942
BPSL1528 Hypothetical protein with role in actin tail
formation, reduced intracellular survival, and
high-grade attenuation of virulence
Pilatz et al. [47] BPSL1528
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NfkB activity is by phosphorylation, and subsequent
inactivation of, glycogen synthase kinase 3b (GSK3b),
which usually supports NfkB activity. This is dysregu-
lated in a rat model of diabetes, resulting in excessive
TNF-a and IL12 cytokine production by peripheral
blood mononuclear cells that may contribute to the higher
risk of septic shock in diabetic patients with melioidosis
[31]. Remarkably, BPS can alter the immune function of
not only the infected host cell, but also uninfected
bystander cells. BPS-infected neutrophils are able to
locally inhibit CD4+ T-cell proliferation and IFN-g pro-
duction via increased surface expression of programmed
death ligand-1 (PDL1) [32]. This trait is exacerbated
diabetes mellitus patients, and the resulting loss of effec-
tive CD4+ T-cell function may contribute to disease
severity and the ability to prevent disease progression.
Phagosome escape and the type three
secretion system
Following uptake by a professional phagocyte, BPS is
contained in a membrane-bound vesicle that matures
through endosomal contact to eventual fusion with the
lysosome, an organelle that by virtue of acidic pH and
degradative enzymes destroys the contents of the phago-
some, allowing denatured proteins to be loaded onto
MHCII molecules for surface expression and engage-
ment of CD4 T-cell immunity.
As the phagosome matures, BPS encounters host pro-
teases that are able to kill the compartmentalised invader.
To counter this, BPS expresses a serine protease inhibitor
called ecotin that enables growth in macrophages and
contributes to virulence in the murine model [33]. Ulti-
mately, however, BPS is able to escape the phagosome
before phagolysosomal fusion occurs, and for this, the
T3SS is essential.
The role of the T3SS in BPS intracellular fitness, and
therefore virulence cannot be overstated. To provide
some context, the capsule of BPS is a well-studied viru-
lence factor that confers protection against antibiotics and
host immune effectors such as complement and antibody
deposition. In a murine model of acute respiratory BPS
infection, capsule mutants were shown to be attenuated
6.8-fold, while T3SS mutants were attenuated 290-fold
[34]. Not only did T3SS mutants show reduced survival,
but were also poorly able to disseminate beyond the site
of infection. Mutation of genes encoding T3SS structural
components, such as bsaQ, impair BPS invasion of macro-
phages and multi- nucleated giant cell (MNGC) forma-
tion due to their inability to evade lysosomal degradation
[35], as well as reducing BPS-induced cytotoxicity [8]. For
this reason, T3SS-related proteins have become attractive
therapeutic targets [36].
The secreted protein effectors that are exported via the
T3SS have diverse effects. For example, a cell-cycle
inhibitor, CHBP (BPSS1385), is able to arrest host cell
division, delay apoptosis and modify the cytoskeleton
[10]. BipC, located within the bsa locus, contributes to
host cell adhesion and invasion, intracellular replication,
cytotoxicity, phagosomal escape [37]. Adjacent to bipC on
the chromosome is bipB, which has similarly been
reported for its role in intracellular BPS infection, includ-
ing induction of MNGC and cell-to-cell spread [38].
The T3SS-dependent liberation of BPS from the phago-
some into the cytoplasm exposes the bacilli to intracellular,
TLR-independent, pattern recognition receptors, namely
the NOD-like receptors (NLR) and by extension to the
machinery of the inflammasome [39]. Sensing of BPS
PAMP, such as flagellin or the T3SS-associated proteins,
BopE and BsaU by NLR4 leads to activation of caspase-1
in early infection [40], subsequently inducing rapid pyr-
optosis of infected cells, thus partly explaining the mecha-
nism of BPS-induced cytotoxicity and the pre-requirement
of T3SS-dependent phagosomal escape. While BopE is a
secreted effector of the T3SS, BsaU is a component of the
secretion apparatus itself, and its disruption compromises
the secretion of other effectors, reducing NfkB-mediated
inflammation in the host cell [41].
BPS infection additionally upregulates NOD2 expression
[42], engagement of which leads to NfkB activation. While
NOD2 is important for limiting early bacterial replication
and partially contains BPS infection, it seems not to
ultimately affect the outcome of survival in vivo [17].
BPS-mediated dysregulation of NfkB may play a role,
as described above, as well an apparent NOD-2-depen-
dent expression of suppressor of cytokine signalling 3 [42].
NOD2 activation has been reported to promote autop-
hagy, a homeostatic process by which cellular contents are
degraded and recycled. An autophagosome is formed
around cytoplasmic material, meaning bacteria that have
escaped the initial phagosome may once again become
membrane entrapped. Autophagy has been shown to be
induced by BPS infection in a T3SS-dependent manner,
and is able to kill the bacteria [43,44]. However, the
effectiveness of autophagy is undermined by expression
of the T3SS effector protein, BopA. Although its mecha-
nism of action remains to be fully elucidated, BopA is
required for evasion of autophagy, and contributes to
intracellular virulence [36,44].
Metabolic challenges in the intracellular
environment
Any intracellular organism finds itself in a conflict for
resources with the host to maintain its metabolic activity.
This is especially true for essential micronutrients such as
iron, which is incorporated into molecules involved in
multiple biological processes. Pathogens such as Mycobac-
terium tuberculosis achieve the sequestration of iron
through the expression of siderophores that have a higher
98 Host-microbe interactions: bacteria
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affinity for the molecule than equivalent host molecules
such as transferrin and lactoferrin. Ferric siderophores are
then recognized by specific receptors on the bacterial
surface. The BPS malleobactin siderophore family is
crucial for its virulence and intracellular survival. They
appear to be remarkably diverse in their peptide struc-
ture, suggesting characteristic adaptability of BPS to
different microenvironmental conditions [45]. Genes that
encode malleobactins as well as other BPS proteins relat-
ing to iron binding and uptake have been shown to be
upregulated in experimentally induced models of iron
deprivation, including oxidative stress [23,46,47]. Besides
the dedicated iron-binding molecules, BPS expresses
proteins with dual function such as BPSL2825 (PabB),
a para aminobenzoate synthetase component important
for metabolism and growth in vitro that takes on a critical
role utilizing hemin as an iron source in vivo [47].
Metabolic flexibility is key to the ability of BPS to adapt
as it moves from in terra to in vivo and it remains one of
its defining features. While several Burkholderia spp.
are similarly well equipped to thrive on multiple
carbon sources, it has been postulated based on genomic
interrogation that virulent species may regulate these
pathways differently from avirulent species, with con-
sequential effects on the expression of virulence factors
[48]. An important requirement of pathogens, whether
they are obligate or facultatively intracellular is their
ability to metabolise fatty acids [49–51]. In bacteria,
fatty acids are required for the formation of cell wall
phospholipids and may be acquired either from existing
host-derived fatty acids, through de novo synthesis or a
combination of both. Since there is no evidence that
BPS is able to acquire host-derived fatty acids, de novo
fatty acid synthesis an attractive target for chemothera-
peutic intervention. FabI is an enoyl-acyl carrier protein
reductase, a key enzyme of the type II fatty acid
synthesis system, and has been shown to be required
for BPS virulence in the murine model of infection. It
has since been successfully targeted by specific chemi-
cal inhibitors [52,53], representing a promising approach
to drug design.
In addition to these processes, anabolic pathways, while
perhaps not traditionally considered virulence factors
are nonetheless essential for intracellular fitness. Anab-
olism requires ATP energy, for which the synthesis of
purine, encoded by the pur gene cluster is required,
purine also being a vital component of nucleic acids [54].
BPS differs from its host in that it is able to synthesise
several amino acids and vitamins that humans cannot
and instead acquire from dietary intake. This also makes
them an attractive target for antimicrobial therapy. For
example, histidine synthesis, encoded by the his gene
cluster, is required for intracellular growth of BPS, and
this area is also being explored for potential future
vaccine design [54].
Cell to cell spread and the Type Six Secretion
System
BPS is able to spread beyond the site of initial infection,
disseminating through the host and potentially infecting
any organ or tissue. One strategy is to use the infected
host cell itself as a vehicle. BPS has been shown to remain
viable within, and induce maturation and migration of,
immature DCs in vitro, a phenomenon seen in other
infections as a route for transport to secondary lymphoid
organs in vivo; although seemingly only a minority of
BPS-infected DCs translocate to the lymph in vivo [55].
More localised spread occurs via a distinctive feature of
BPS infection, namely its ability to create MNGC. Arising
from the fusion of cell membranes between an infected
cell and a neighbouring, uninfected cell, it is a phenome-
non that enables continued intracellular replication, and
cell to cell spread without the requirement of an extra-
cellular step and the consequences that entails regarding
host immunity. BPS is able to form MNGC in both
phagocytic and non-phagocytic cells within hours of in-
fection [56], and the eventual death of the MNGC results
in plaque formation [57] that is damaging to the host, and
may serve as a niche for further BPS replication.
It is well established that cell–cell spread and induction of
MNGC requires bacterial motility. In addition to the two
flagellin encoding genes, fla2 on chromosome 2 and fla1 on
chromosome 1, BPS achieves intracellular motility through
the action of the autotransporter, BimA. Localising to one
pole of the bacillus, it binds host actin, polymerisation of
which pushes the bacteria through the cytoplasm, leaving
in its wake characteristic ‘comet tails’. BimA localisation is
not itself directed to the poles, rather it is transported
equally across the bacterial inner membrance [58]. BimA
localisation depends on the polarity of its partner protein,
BimC, which functions through an iron-dependent mech-
anism that remains to be fully described.
Interestingly, BimA is also expressed by B. thailandensis
which is avirulent in humans. Recent published work has
revealed the finer distinction responsible for virulence:
whereas B. thailandensis BimA mimics the host Arp3/3
actin polymerase complex, BimA from BPS and B. mallei,
another pathogenic member of the genus that causes the
disease, glanders, in horses, instead mimic the far more
efficient host Ena/VASP complex to initiate and elongate
actin filaments [59,60]. The result is that while B.
thailandensis BimA is able to generate branched actin
networks, BPS BimA generates multiple bundles of fila-
ments; moreover, BPS BimA is able to generate more
actin tails and larger MNGC compared with B. mallei
BimA, highlighting the key importance of actin-based
motility for cell–cell spread in the host.
In addition to bacterial motility, a key requirement
for cell fusion and MNGC formation is the Type Six
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Secretion System (T6SS), disruption of which attenuates
virulence in vivo. BPS possesses a predicted six T6SS
gene clusters, which are thought to have evolved as a
weapon for inter-bacterial competition [61] within the
rhizosphere, the native microbiome of BPS.
While the T3SS is not directly required for MNGC
formation, it is a prerequisite that the bacteria are able
to escape the phagocytic vacuole [39,57]. Furthermore,
there is cross-talk between the T6SS and T3SS; for
example, T6SS1 expression is regulated by BprC, which
is located in the T3SS gene cluster. The T6SS is upre-
gulated by several orders of magnitude upon infection of
host cells, and this is largely regulated by the two-com-
ponent histidine kinase sensor, VirAG [62], which is itself
regulated by a T3SS regulator, BsaN [63]. Mutagenesis
studies have revealed that abrogation of both virAG and
bprC function attenuates virulence in the murine model
of BPS infection [63].
VirAG activates the promoter of a key T6SS effector,
hemolysin-coregulated protein (Hcp), located in gene
cluster five out of the six BPS T6SS gene clusters
[63]. Solving the crystal structure of BPS Hcp has
revealed unique variations in its tertiary structure that
are not present in orthologues from avirulent species,
hinting at its key role in virulence.
Hcp polymerases the hexameric ring structures that com-
prise the T6SS, forming an overall structure that is akin to
the bacteriophage tailspike. Hcp is also secreted by the
T6SS, dependant on the protein, BPSS1504 [64], and
functions as a chaperone for other secreted effectors,
localising to the infected cell plasma membrane. Exoge-
nous recombinant Hcp also localises to the host cell
surface, preferentially targeting antigen presenting cells.
Accordingly, it has been found to be highly immunogenic
and reacts strongly with sera from melioidosis patients
[65]. The consequence of this is not clear, but it has been
reported that binding of Hcp induces the anti-inflamma-
tory cytokines, IL-10 and TGF-b, potentially interfering
with the mounting of a robust immune response to other
epitopes besides Hcp.
Activation of T6SS is a dynamic, multi-step process that
begins with assembly of the inner tube, comprised of
Hcp, its outer sheath and baseplate at the bacterial cell
wall-host cell membrane interface. The tip of the T6SS
spike is comprised of a trimer of the protein, Valine-
glycine repeat protein G (VgrG) [66]. VgrG tranverses the
inner membrane, periplasmic space and peptidoglycan
layer of the bacterial cell wall, while the elongation of the
tail spike extends into the bacterial cytoplasm.
Upon contact with the host cell membrane, the T6SS
outer sheath contracts and provides the kinetic energy for
the inner tube to propel the VgrG tip, penetrating the host
cell and potentially into the neighbouring cell membrane
[67]. At this stage, T6SS effector proteins are also deliv-
ered. The recruitment of ATPase then disassembles the
outer sheath proteins, which are recycled [68]. The con-
traction of the T6SS may serve to pull the two membranes
close enough whereupon, according to the hemifusion
paradigm, membrane fusion occurs when proximity is
<1 nM [69], resulting in a fused, multinucleated cell.
Although VgrG has been shown to be functionally con-
served across Burkholderia spp., some species such as B.
oklahomensis lack the ability of cell–cell spread, suggesting
other requisites than VgrG alone [66].
Conclusions and future perspectives
Much has been learned in recent years about how BPS is
able to infect human cells, evade immune killing mech-
anisms and replicate intracellularly.  This review is not
an exhaustive list of BPS virulence factors. Several are
the subject of ongoing research to fully explain their
function, such as boaB, bpaC and bpaE, which all con-
tribute to virulence in the murine infection model [70].
Still more targets remain to be identified and under-
stood, and newly emerging tools will help to expedite
these efforts. For example, transposon-directed inser-
tion-site sequencing (TraDIS) also known as TnSeq,
has facilitated the discovery of the essential gene set of
BPS [4] and B. thailandensis [71] and has very recently
been applied to elucidate virulence genes in the acute
model of in vivo infection [72]. A particular remaining
challenge is to understand the establishment of chronic
infection with BPS, which may demand novel treatment
therapies in the clinical setting [73]. We have gained
important insights into the pathogenicity of BPS, for
example the significance of the T3SS and T6SS, and
some of the basic cell biology of infection. Further work
is needed to understand the subtleties of host-pathogen
interactions that result in, or fail to result in, protective
host immunity. Together these efforts will contribute to
our ability to counteract the emerging threat of this
well-armed pathogen.
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